Merrimack Pharmaceuticals, Inc. Gross Margin 2010-2024 | MACK

Current and historical gross margin for Merrimack Pharmaceuticals, Inc. (MACK) over the last 10 years. The current gross profit margin for Merrimack Pharmaceuticals, Inc. as of March 31, 2024 is %.
Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2015-09-30 $0.10B $0.10B 100.00%
2015-06-30 $0.11B $0.11B 100.00%
2015-03-31 $0.11B $0.11B 100.00%
2014-12-31 $0.10B $0.10B 100.00%
2014-09-30 $0.08B $0.08B 100.00%
2014-06-30 $0.06B $0.06B 100.00%
2014-03-31 $0.05B $0.05B 100.00%
2013-12-31 $0.05B $0.05B 100.00%
2013-09-30 $0.05B $0.05B 100.00%
2013-06-30 $0.06B $0.06B 100.00%
2013-03-31 $0.05B $0.05B 100.00%
2012-12-31 $0.05B $0.05B 100.00%
2012-09-30 $0.05B $0.05B 100.00%
2012-06-30 $0.05B $0.05B 100.00%
2012-03-31 $0.04B $0.04B 100.00%
2011-12-31 $0.04B $0.04B 100.00%
2011-09-30 $0.03B $0.03B 100.00%
2011-06-30 $0.03B $0.03B 100.00%
2011-03-31 $0.02B $0.02B 100.00%
2010-12-31 $0.02B $0.02B 100.00%